Why this matters GLP-1 drugs are transforming diabetes & obesity treatment globally Current therapies like semaglutide are highly effective but expensive Patent expiries could unlock more affordable access for millions Indian pharma players already positioning themselves: Glenmark Pharmaceuticals - Low-cost semaglutide version planned Dr
[DOI] [PubMed] [Google Scholar] 2.Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR
The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging (Metabolism: Clinical and Experimental)
Brain GLP-1 agonists like semaglutide interact with neurons found in the hunger center of the brain
It translocates to the nucleus and induces the production of anorectic neuropeptide POMC, while repressing the production of orexigenic neuropeptide AgRP
Look for manufacturers that publish stability testing or give explicit storage guidance